Male breast cancer (MaBC) is a rare clinical entity, which makes up approximately 1% of all
breast cancers. However, the incidence of MaBC has been steadily increasing over the past …

Male breast cancer (MBC) is a rare condition that accounts for 0.1% of all male cancers. Our
current evidence base for treatment is derived from female breast cancer (FBC) patients …

Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Although breast carcinomas share certain characteristics in both …

Male breast cancer (MaBC) is a rare disease, accounting for less than 1% of malignancies in
men. For this reason, literature data on its clinicopathological characteristics are very …

Male breast cancer is rare, accounting for 1% of all breast cancer diagnoses in the USA.
Because of its rarity, most major breast cancer trials have included only female patients. This …

Background Male breast cancer (MBC) is rare. Given the paucity of randomized trials,
treatment is generally extrapolated from female breast cancer guidelines. Methods This is a …

Unlike female breast cancer, male breast cancer (MBC) is rare and not very well understood.
Prospective data in the management of MBC are lacking and majority of treatment strategies …

Male breast carcinomas (MBCs) are rare neoplasms that account for 0.1% of all male
cancers. Still, there are 2000 new cases of MCB diagnosed annually in the United States …

Male breast cancer is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Most data on male breast cancer comes from small single-institution …

Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the
incidence has increased worldwide. Risk factors include increased longevity, obesity …